Cranswick Plc was founded in 1975 and is headquartered in Hessle, UK. It operates about 12 production facilities and has around 12,400 employees. The company is a vertically integrated supplier of premium fresh and added-value food products. It operates through two segments: Food, which manufactures and supplies food products to UK grocery retailers, food service sectors, and global producers; and Other, which includes Cranswick Pet Products Limited.

The company offers a variety of fresh products such as pork, poultry, gourmet items, and convenience foods. Its food portfolio features items like gourmet sausage, bacon, chicken, pastry, charcuterie, houmous, dips, and cooked meats. Cranswick's brands include Ramona’s, Cypressa, and Bodega. In addition, it produces pet food under brands like Vitalin and Alpha Feeds and is involved in pig genetics and farming.

Cranswick primarily operates in the food sector, accounting for 98% of FY 25 net sales, with the remaining 2% from other segments. Geographically, it serves the UK (97%), continental Europe (1%), and the rest of the world (2%).

Strategic expansion through acquisitions

In 2025, Cranswick made two key acquisitions to strengthen its integrated supply chain and expand its presence in value-added meat segments. In January 2025, Cranswick acquired JSR genetics Ltd and its subsidiary JSR pyramid Ltd for £24.4m. The deal included pig farming, and artificial insemination services, with around 70 employees. The acquisition secures a reliable supply chain of high-quality indoor pigs, enhancing efficiency, meat quality, and long-term sustainability.

In May 2025, Cranswick further expanded its operations by acquiring James T Blakeman and Co, a specialist sausage manufacturer, for £32m. This bolt-on acquisition enhances Cranswick’s gourmet kitchen division adds capacity to serve restaurants, fish and chip shops, and ready-meal producers. Together these acquisitions focus on vertical integration, and supply chain control. This strategic move enables Cranswick for sustainable, long-term growth in the UK meat industry.

Solid growth in cash balance

Cranswick has reported a decent performance over FY 22-25, posting a revenue CAGR of 10.7%, reaching £2.7bn. This was driven by robust demand for its premium food products and strategic growth in its product lines. EBIT rose at a CAGR of 14.3% to £204m, with margins expanding by 68bp to 7.5%, helped by excellent capacity utilization and tight cost controls. Net income increased to 9.1% CAGR over the same period, reaching £134m on FY 24.

FCF rose from £35.7m in FY 22 to £48.7m in FY 25. Cash and cash equivalent rose from £0.2m at end-FY 22 to £5.9m at end-FY 25, helped by a positive earnings trajectory and steady cash inflow from operations, while offset somewhat by acquisitions. The company’s ROA rose from 7.8% in FY 22 to 8.8% on FY 25, reflecting improved profitability and the efficient use of assets.

In comparison, Premier Foods plc, a local peer, reported a (lower) revenue CAGR of 8.5% over the past three years, reaching £1.2bn in FY 25. EBIT rose at a CAGR of 11.4% to £181m in FY 25. Net income rose at a CAGR of 17.2% to £125m.

Positive views amongst analysts 

Over the past 12 months, the company has delivered a solid return of approximately 15.9%, reflecting a positive fundamental trajectory. In comparison, Premier Foods delivered lower returns of approximately 10.5%.

Cranswick is currently trading at a P/E of 19.3x, based on the FY 26 estimated EPS of £2.70, which is higher than its 3-year average of 18x, indicating a modest premium compared to its own historical trading averageand that of Premier Foods (15x).

Likewise, the company is currently trading at an EV/EBIT multiple of 13.6x, based on the FY 26 estimated EBIT of £218.1m, which is higher than its three-year historical average of 12.6x and Premier Foods’ multiple of 9.1x.

Cranswick is monitored and largely liked by nine analysts, with five having “Buy” ratings, one with an “Outperform” rating and two having “Hold” ratings. They have an average target price of £57.4, implying 9.3% upside potential from the share's current price.

Analysts’ views are further supported by an anticipated EBIT CAGR of 5.6% over FY 25-28, reaching £243.3m, with a margin of 7.5% in FY 28. In addition, analysts estimate a net profit CAGR of 8.1% reaching £169.6m, with a margin of 5.3% in FY 28, with EPS expected to increase to £3.0 in FY 28 from £2.5 in FY 25. In comparison, analysts estimate a lower EBIT CAGR of 3.1% and net profit CAGR of 2.2% for Premier Foods.

Overall, the company has demonstrated consistent and robust growth over the past few years. The company expanded its margins and enhanced its overall earnings. Strategic acquisitions have enhanced vertical integration, increased production capacity, and secured supply chain stability.

However, there are notable risks from fluctuating input costs, particularly in livestock and feed, which can impact margins. Supply chain disruptions and disease outbreaks in livestock may affect production. In addition, heavy resilience on the UK market increases vulnerability to domestic economic and regulatory changes.